Barclays’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$884K Buy
181,546
+120,855
+199% +$588K ﹤0.01% 2729
2025
Q1
$224K Buy
60,691
+6,131
+11% +$22.6K ﹤0.01% 3273
2024
Q4
$218K Sell
54,560
-8,296
-13% -$33.1K ﹤0.01% 3473
2024
Q3
$439K Buy
62,856
+50,582
+412% +$353K ﹤0.01% 3068
2024
Q2
$70K Buy
12,274
+7,857
+178% +$44.8K ﹤0.01% 3541
2024
Q1
$59K Hold
4,417
﹤0.01% 3787
2023
Q4
$27K Hold
4,417
﹤0.01% 3932
2023
Q3
$11K Hold
4,417
﹤0.01% 4015
2023
Q2
$23K Hold
4,417
﹤0.01% 3945
2023
Q1
$21K Sell
4,417
-20
-0.5% -$95 ﹤0.01% 3989
2022
Q4
$24K Sell
4,437
-1
-0% -$5 ﹤0.01% 3993
2022
Q3
$31K Sell
4,438
-106
-2% -$740 ﹤0.01% 3806
2022
Q2
$42K Sell
4,544
-645
-12% -$5.96K ﹤0.01% 3794
2022
Q1
$93K Sell
5,189
-4,180
-45% -$74.9K ﹤0.01% 3707
2021
Q4
$246K Buy
9,369
+1,645
+21% +$43.2K ﹤0.01% 2771
2021
Q3
$277K Buy
7,724
+1,844
+31% +$66.1K ﹤0.01% 2838
2021
Q2
$322K Sell
5,880
-39,047
-87% -$2.14M ﹤0.01% 2686
2021
Q1
$3.73M Buy
44,927
+43,302
+2,665% +$3.59M ﹤0.01% 1403
2020
Q4
$185K Sell
1,625
-153
-9% -$17.4K ﹤0.01% 2728
2020
Q3
$54K Sell
1,778
-154
-8% -$4.68K ﹤0.01% 3256
2020
Q2
$84K Buy
1,932
+1,496
+343% +$65K ﹤0.01% 3188
2020
Q1
$15K Sell
436
-2,772
-86% -$95.4K ﹤0.01% 3432
2019
Q4
$214K Buy
3,208
+2,556
+392% +$171K ﹤0.01% 3147
2019
Q3
$101K Sell
652
-1,479
-69% -$229K ﹤0.01% 3397
2019
Q2
$184K Sell
2,131
-26,440
-93% -$2.28M ﹤0.01% 3246
2019
Q1
$3.94M Buy
28,571
+28,532
+73,159% +$3.94M ﹤0.01% 1115
2018
Q4
$16K Sell
39
-396
-91% -$162K ﹤0.01% 3445
2018
Q3
$308K Buy
435
+240
+123% +$170K ﹤0.01% 2865
2018
Q2
$104K Buy
195
+70
+56% +$37.3K ﹤0.01% 3045
2018
Q1
$14K Buy
+125
New +$14K ﹤0.01% 3902